A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 Jun 2018
At a glance
- Drugs Cytomegalovirus immune globulin (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 12 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 Nov 2018.
- 12 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 25 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.